Neuroinflammation, White Matter Integrity, AD Biomarkers and Pathology in Corticobasal Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Age 18 years or older

• Meet possible or probable CBS criteria

Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Megan J Meyer, M.B.A.
meyer.megan6@mayo.edu
507-293-1164
Backup
Sarah M Boland, CCRP
boland.sarah@mayo.edu
507284-3863
Time Frame
Start Date: 2025-06-25
Estimated Completion Date: 2031-03-30
Participants
Target number of participants: 80
Treatments
Corticobasal Syndrome
patients diagnosed with cbs
Healthy Control
Healthy Control Volunteer
Related Therapeutic Areas
Sponsors
Leads: Jennifer Whitwell
Collaborators: National Institute on Aging (NIA)

This content was sourced from clinicaltrials.gov